Tag:
Bill and Melinda Gates Foundation
Latest Headlines
Latest Headlines
Swiss team envisions cheap, durable Dx imaging for Africa
Researchers at Switzerland's Federal Institute of Technology in Lausanne are developing an inexpensive, easy-to-use radiology machine that's functional in sub-Saharan Africa and elsewhere in the developing world where conditions are pretty rough.
Alere snags up to $42.2M from Gates Foundation for TB Dx
Diagnostics magnate Alere has hooked up with the Bill and Melinda Gates Foundation to develop a tuberculosis assay and support its point-of-care HIV test.
Bitter setback as TB vaccine fails to protect infants in key study
A closely watched study of a new Gates-backed tuberculosis vaccine--MVA85A--failed to deliver desperately hoped-for data that it could guard infants against the lethal disease. Investigators said the jab failed to prove that it had a comparable effect as that seen in a study involving adults.
GSK reports letdown in PhIII malaria vaccine study
GSK plans to keep advancing the program, which has garnered millions of dollars in support from the Bill & Melinda Gates Foundation, according to the London-based drugmaker.
Gates Foundation backs $13M venture add for flu drug developer
The Bill & Melinda Gates Foundation has stepped up with another equity investment in a biotech company, this time making a major contribution to a $13 million Series A add for a startup aiming at a universal preventive as well as therapeutic approach to influenza. Omega Funds also joined the venture top-up, bringing the first venture round for Cambridge, MA-based Visterra to $26 million.
Gates Foundation jumps into $30M round for Genocea's T cell vaccines
The 2008 Fierce 15 biotech Genocea Biosciences has picked up a key endorsement and a sizeable amount of cash today as the Bill & Melinda Gates Foundation joined a bevy of venture investors backing a $30 million C round.
Gates Foundation readies a round of tempting biotech investments
A little more than a year ago the Bill & Melinda Gates Foundation made waves when it invested $10 million in Liquidia Technologies. After seeding a host of research efforts with billions of dollars in grant money contributed by the software mogul, the foundation opted for an equity stake in place of one of its usual contributions.
Nasal RSV vax shows promise in the lab
A team at the University of Saskatchewan, along with VIDO-InterVac, is developing a nasal vaccine against respiratory syncytial virus that shows promise in the lab.
13 Big Pharmas to collaborate on $785M fight against neglected diseases
Top executives from a slate of the world's biggest pharma companies will be rubbing shoulders with Bill Gates today as they roll out an ambitious plan to join hands on a $785 million effort to
Gates' legendary discipline transforms vaccine effort
Forbes' Matthew Herper provides a cover story on Bill Gates' multibillion-dollar effort to change the world with a new generation of cheap vaccines that will save millions of lives. And Gates is
